Latest Strategic Partnerships News

Page 18 of 252
PLS Group reported a robust first half of FY26, with lithium production up 6% and a 40% jump in realised prices driving a 47% revenue increase. Underlying EBITDA soared 241%, underscoring operational efficiency and cost discipline.
Maxwell Dee
Maxwell Dee
19 Feb 2026
Rhythm Biosciences reported a $2.26 million half-year loss as it advances ColoSTAT into commercialisation and expands geneType partnerships, signalling a pivotal phase for the ASX-listed medical diagnostics company.
Ada Torres
Ada Torres
18 Feb 2026
Knosys Limited reported a 4.6% revenue increase to $5.07 million for the half-year ending December 2025, driven by stronger licence and project fees. However, the company’s net loss widened significantly to $1.53 million, reflecting heavy investment in its next-generation Libero X library management system.
Sophie Babbage
Sophie Babbage
18 Feb 2026
Cleo Diagnostics has chosen Bio-Techne’s next-generation Ella™ platform to enhance its ovarian cancer blood test, aiming for faster, more precise results and a streamlined path to FDA approval.
Ada Torres
Ada Torres
18 Feb 2026
EV Resources has successfully produced its first metallic antimony ingots from the Los Lirios project in Mexico, validating a low-cost smelting process and advancing its strategy to supply the North American market.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Star Minerals has entered a strategic partnership with Catalyst Metals, securing a gold milling agreement for its Tumblegum South project and selling its West Bryah Basin copper-gold assets for $2.75 million. Catalyst also commits to a $1 million equity placement in Star Minerals, underpinning the company’s development plans.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Magellan Financial Group has reported a 5% rise in operating earnings per share and a striking 50% increase in its fully franked interim dividend, underpinned by strong contributions from strategic partnerships and disciplined capital management.
Claire Turing
Claire Turing
18 Feb 2026
Magellan Financial Group reported a 27% drop in statutory net profit but maintained stable operating profit and increased earnings per share by 5%, supported by ongoing share buybacks. The company declared a fully franked interim dividend up 50%, reflecting confidence despite investment performance challenges.
Claire Turing
Claire Turing
18 Feb 2026
Starpharma reports a $1.37 million profit for H1 FY26, driven by a major upfront payment from Genentech and progress in its radiopharmaceutical pipeline. The biotech also expands its consumer health footprint amid growing partnerships.
Ada Torres
Ada Torres
18 Feb 2026
Hansen Technologies has reported a remarkable half-year performance with a 7.3% revenue increase and a staggering 31,000% rise in statutory net profit, underpinned by a strategic acquisition of the Digitalk Group.
Sophie Babbage
Sophie Babbage
18 Feb 2026
Netwealth Group Limited has reported a robust first half of FY26, with record funds under administration and a significant increase in dividends, underpinned by strong inflows and strategic technology investments.
Claire Turing
Claire Turing
18 Feb 2026
BCAL Diagnostics reported a slight revenue decline and a persistent net loss in its half-year results, with auditors flagging concerns over its ability to continue without additional funding.
Ada Torres
Ada Torres
17 Feb 2026